Assignee
MOERAE MATRIX INC
US·6 granted patents·5 pending applications·4 citations·filing 2014–2019
Top patents by PatentIndex Score
11 records- 0171US10336788B2Inhibition of cardiac fibrosis in myocardial infarctionMOERAE MATRIX INC·Filed 2014·Granted Jul 2, 2019·1 cites·14 claims
- 0268US9890200B2Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 0366US10087225B2Formulation of MK2 inhibitor peptidesMOERAE MATRIX INC·Filed 2016·Granted Oct 2, 2018·1 cites·37 claims
- 0466US9999655B2Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with sameMOERAE MATRIX INC·Filed 2016·Granted Jun 19, 2018·1 cites·24 claims
- 0558US10562947B2Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2017·Granted Feb 18, 2020·0 cites·25 claims
- 0655US2020172574A1Inhibition of cardiac fibrosis in myocardial infarctionMOERAE MATRIX INC·Filed 2019·Application pending·0 cites
- 0752US2019022169A1Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2017·Application pending·0 cites
- 0845US2019031730A1Formulation of mk2 inhibitor peptidesMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
- 0940US10500249B2Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix depositionMOERAE MATRIX INC·Filed 2015·Granted Dec 10, 2019·0 cites·16 claims
- 1039US2019022176A1Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with sameMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
- 1139US2019134153A1Immunomodulatory effect of inhaled kinase inhibitor peptides in lungMOERAE MATRIX INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MOERAE MATRIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →